Press release
KalVista Pharmaceuticals to Present Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on
About this update from Kalvista Pharmaceuticals, Inc.
[{"type":"text","content":" CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--\nKalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the acceptance of multiple abstracts at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI), taking place in Anaheim, CA from November 9-13. The presentations are:\n\n\n\nUnderstanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with Them - #P078: Bob Geng, Sally van Kooten, Markus Heckmann, Sherry Danese, Ledia Goga, Cristine Radojicic. Results shared as an oral poster presentation and Q&A on Friday, November 10 from 4:30 - 4:45 pm PT at Monitor 13\n\n\n\nTreatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real-World ACARE Survey - #P059: Marcus Maurer, Markus Magerl, Marc A. Riedl, Sherry Danese, Julie Ulloa, Vibha Desai, Paul K. Audhya. Results shared as an oral poster presentation and Q&A on Friday, November 10 from 5:15 - 5:30 pm PT at Monitor 12\n\n\n\nTreatment Patterns Among Individuals with Hereditary Angioedema in the United States - #P085: Raffi Tachdjian, Rose Chang, Maral DerSarkissian, Kristen A. Cribbs, Betsy J. Lahue, Shawn Czado, Vibha Desai. Results shared as an oral poster presentation and Q&A on Saturday, November 11 from 11:50 am - 12:05 pm PT at Monitor 13\n\n\n\nDiagnosing Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real World ACARE Survey - #P069: Marc A. Riedl, Markus Magerl, Marcus Maurer, Sherry Danese, Julie Ulloa, Vibha Desai, Paul K. Audhya. Results shared as an oral poster presentation and Q&A on Sunday, November 12 from 12:05 - 12:20 pm PT at Monitor 12\n\n\n\nRefining Prevalence Estimates of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) - #P070: Markus Magerl, Marc A. Riedl, Marcus Maurer, Sherry Danese, Julie Ulloa, Vibha Desai, Paul K. Audhya. Results shared as an oral poster presentation and Q&A on Sunday, November 12 from 12:20 - 12:35 pm PT at Monitor 12\n\n\n\nAnxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management - #P092: Michael Manning, Sally van Kooten, Markus Heckmann, Sherry Danese, Ledia Goga, Princess U. Ogbogu. Results shared as an ...